Joanna Peterkin
About
In The Last Decade
Joanna Peterkin
16 papers receiving 516 citations
Peers
Comparison fields: 5 of 73
- Infectious Diseases 258
- Virology 189
- Oncology 117
- Molecular Biology 106
- Genetics 76
Countries citing papers authored by Joanna Peterkin
This map shows the geographic impact of Joanna Peterkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joanna Peterkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joanna Peterkin more than expected).
Fields of papers citing papers by Joanna Peterkin
This network shows the impact of papers produced by Joanna Peterkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joanna Peterkin. The network helps show where Joanna Peterkin may publish in the future.
Co-authorship network of co-authors of Joanna Peterkin
This figure shows the co-authorship network connecting the top 25 collaborators of Joanna Peterkin. A scholar is included among the top collaborators of Joanna Peterkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joanna Peterkin. Joanna Peterkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 14 | |
| 2 | 36 | |
| 3 | 27 | |
| 4 | 21 | |
| 5 | 35 | |
| 6 | 15 | |
| 7 | 0 | |
| 8 | 1 | |
| 9 | iSONEPTM , an Anti-Sphingosine-1-Phosphate (Anti-S1P) Monoclonal Antibody for Investigation in Exudative AMD: Results From a Phase 1 Prospective Open-Label Dose-Escalating Multi-Center Study | 4 |
| 10 | 18 | |
| 11 | 11 | |
| 12 | 91 | |
| 13 | 120 | |
| 14 | 123 | |
| 15 | Clinical potential of a new HIV protease inhibitor. | 2 |
| 16 | 1 | |
| 17 | Depression in the context of human immunodeficiency virus infection: implications for treatment. | 34 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.